Physician profile
Celeste E Halcomb
NPI 1023265113
$1,295.90
in general payments reported to CMS, 2019-2025
17 companies · $493 in 2025
The $493 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $79.33 · 2022: $236 · 2023: $231 · 2024: $257 · 2025: $493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $981.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $980.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $236.69 | 2022-2025 | |
| Corium, LLC | $191.07 | 2022-2025 | Azstarys |
| Tris Pharma INC | $140.94 | 2021-2025 | Dyanavel Xr |
| Seqirus USA INC | $110.49 | 2022-2025 | Flucelvax, Flucelvax Quadrivalent |
| Collegium Pharmaceutical, INC. | $92.19 | 2025 | Jornay Pm |
| Sanofi Pasteur INC. | $78.45 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $78.01 | 2024-2025 | |
| Acadia Pharmaceuticals INC | $76.55 | 2025 | Daybue |
| Merck Sharp & Dohme LLC | $72.21 | 2022-2025 | Gardasil 9, Vaxneuvance, M-M-R II |
| Cranial Technologies, INC | $52.31 | 2025 | Doc Band |
| Astrazeneca Pharmaceuticals Lp | $49.63 | 2024 | Flumist Quadrivalent |
| Ironshore Pharmaceuticals INC. | $30.69 | 2022-2023 | Jornay Pm |
| Novo Nordisk INC | $22.14 | 2025 | |
| Mirum Pharmaceuticals, INC. | $20.23 | 2023 | Livmarli |
| Neurelis, INC. | $16.51 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $14.94 | 2022 | |
| Genentech USA, INC. | $12.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Celeste Halcomb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.